Companies across the cannabis industry announce financial results for the first quarter of 2022, Cannabis Wealth rounds up the results of six major firms expanding within...
Apollon Formularies has announced the acquisition of four patents previously owned by AI Pharmaceuticals, covering a number of treatments for cancers and inflammation using cannabis and...
The platform aims to be a premium destination for industry members to connect.
Akanda has now completed its acquisition of Holigen Limited from The Flowr Corporation.
A new cannabis-themed ETF has launched this 4/20 giving investors the opportunity to capitalise on the growing North American market.
The new Prohibition Partners report projects that sales of adult-use cannabis in Europe could reach €1.5bn by 2026.
Promising results reported from studies testing the efficacy of its lead compound.
Inflation is at a record high, but cannabis prices are continuing to fall.
The CBX Stock Exchange will offer “seed to shelf” transparency.
Medical cannabis products can now be bought and sold via Canxchange's electronic trading infrastructure.
